TY-9591
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for TY-9591, covering 2024-01-30 to 2024-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation [Phase 2]